Bright Minds Biosciences (DRUG) Share-based Compensation (IS) (2020 - 2026)
Bright Minds Biosciences (DRUG) reported Share-based Compensation (IS) of $878672.4 for Q1 2026, up 104.71% on a YoY basis from $429236.4 in Q1 2025, and down 4.66% quarter-over-quarter from $921592.8 in Q4 2025.
Bright Minds Biosciences (DRUG) Share-based Compensation (IS) (2020 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Share-based Compensation (IS) for 7 years, with the latest figure at $878672.4 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (IS) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1.45 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 892,057.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 14.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - | 878,672.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 878,672.44 |
| Mar 31, 2026 | 878,672.44 |
| Dec 31, 2025 | 921,592.84 |
| Dec 31, 2025 | 921,592.84 |
| Jun 30, 2025 | 953,650.69 |
| Jun 30, 2025 | 953,650.69 |
| Mar 31, 2025 | 429,236.43 |
| Mar 31, 2025 | 429,236.43 |
| Dec 31, 2024 | 126,269.35 |
| Dec 31, 2024 | 126,269.35 |
| Jun 30, 2024 | 134,486.72 |
| Jun 30, 2024 | 134,486.72 |
| Mar 31, 2024 | 168,194.02 |
| Mar 31, 2024 | 168,194.02 |
| Dec 31, 2023 | 160,825.82 |
| Dec 31, 2023 | 160,825.82 |
| Jun 30, 2023 | 176,833.52 |
| Jun 30, 2023 | 176,833.52 |
| Mar 31, 2023 | 22,158.34 |
| Mar 31, 2023 | 22,158.34 |